22-19759628-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080647.1(TBX1):c.-16A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080647.1 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX1 | NM_080647.1 | c.-16A>C | 5_prime_UTR_variant | Exon 2 of 9 | NP_542378.1 | |||
TBX1 | NM_080646.2 | c.-16A>C | 5_prime_UTR_variant | Exon 2 of 9 | NP_542377.1 | |||
TBX1 | NM_005992.1 | c.-16A>C | 5_prime_UTR_variant | Exon 2 of 10 | NP_005983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX1 | ENST00000332710 | c.-16A>C | 5_prime_UTR_variant | Exon 2 of 9 | 1 | ENSP00000331791.4 | ||||
TBX1 | ENST00000329705 | c.-16A>C | 5_prime_UTR_variant | Exon 2 of 9 | 1 | ENSP00000331176.7 | ||||
TBX1 | ENST00000359500 | c.-16A>C | 5_prime_UTR_variant | Exon 2 of 10 | 1 | ENSP00000352483.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459656Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 726120
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: TBX1 c.-16A>C is located in the untranslated mRNA region upstream of the initiation codon. The variant was absent in 244936 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.-16A>C in individuals affected with TBX1-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at